Johnson & Johnson to acquire Actelion Ltd. by mid-June 2017 via its reputed subsidiary, Janssen Holding GmbH
Date: 2017-06-23   Author: Saipriya Iyer  Category: #market

Johnson & Johnson to acquire Actelion Ltd. by mid-June 2017 via its reputed subsidiary, Janssen Holding GmbH

Johnson & Johnson, the renowned participant of global pharmaceutical industry, declared that its acquisition deal worth USD 30 billion, with Actelion Limited, a Swiss-based biopharmaceutical major, has been sanctioned by the European Commission. The approval, which was granted by the antitrust authorities of the European Union was subject to the conditions that the deal would not interfere or affect the production of insomnia medicines. The U.S. pharmaceutical major stated that it anticipates the settlement of an all-cash public tender offered by the Janssen Holding GmbH, a Swiss subsidiary of Johnson & Johnson, on 16th June 2017. As per the tender, Janssen will buy all the public shares of Actelion for USD 280 per share on the aforementioned date.

As per the transaction, Actelion will spin-off its medicine discovery functions and early-phase clinical development assets into its newly formed firm referred to as Idorsia Limited. The shares of the latter are predicted to be distributed to the stakeholders of Actelion in the form of dividends. They are also expected to get listed on the Swiss stock exchange on June 16, 2017, the date of the public tender offer settlement.  Idorsia Ltd.  is expected to focus more on the drug discovery activities and the creation of small molecules useful in treatment of orphan disorders, immunological ailments, neurological disorders, and heart ailments. The spinoff will help Actelion to focus more on its core competencies such as orphan ailment treatment and medical research & development activities.

Janssen Holding GmbH, will get 9.9% of the shares of the newly established firm, Idorsia Limited. The former will also have the rights to increase its share up to 32% via a convertible note. As per industry analysts, these acquisitions are expected to help Johnson & Johnson expand its biotechnology and pharmaceuticals business across the globe.

For the record, Actelion had mentioned that it had already published the prospectus related to the listing of the shares in Idorsia. This spin-off company is expected to be led by the current Actelion Chief Executive, Jean-Paul Clozel. This acquisition is expected to expand the business scope of Actelion, which is already a renowned name across the globe, and is reputed for specializing in the departments of drug discovery, development & commercialization to fulfill the unmet medical requirements of the patient base across the world.



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

RF Low-Noise Amplifiers (LNAs) Market: Industry Analysis, Trend, Growth, Opportunity, Forecast 2020-2025
Author: Sachin Pashte

Market Study Report LLC adds new report on Global RF Low-Noise Amplifiers (LNAs) Market Research, which contains company information, geographical data and market analysis about this industry for all stakeholders involved in or wanting to get into...


5G Antenna Switch Module Market SWOT Analysis of Top Key Player & Forecasts To 2025
Author: Sachin Pashte

This report provides a strategic analysis of the Global 5G Antenna Switch Module market and the growth estimates for the forecast period. This report also provides market sizing and forecasts for the Global 5G Antenna Switch Module market.

T...


5G Chip Antenna Market Future Challenges and Industry Growth Outlook 2025
Author: Sachin Pashte

Global 5G Chip Antenna Market analysis is provided for the major regions of the world, including development trends, competitive landscape analysis, and key regions development status.

The research report on 5G Chip Antenna market provides a...